What is Gufic BioSciences Ltd (GUFICBIO) share price today?

Gufic BioSciences Ltd (GUFICBIO) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/GUFICBIO for the latest live price, technical analysis, and AI-powered insights.

How to analyse GUFICBIO stock?

VestAI provides comprehensive GUFICBIO stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Gufic BioSciences Ltd in?

Gufic BioSciences Ltd (GUFICBIO) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Gufic BioSciences Ltd

Q: What is Gufic BioSciences Ltd's Orion Score?

Gufic BioSciences Ltd has an Orion Score of 49/100 (Caution) — a fundamentals-based quality & risk score. Gufic BioSciences Ltd scores 49/100 (Caution) on the Orion Score — moderate business quality (59), moderate growth (52), weak balance-sheet safety (47) and rich valuation (21). A fundamentals-based quality & risk score, not a buy/sell recommendation.

GUFICBIO

NSE· Healthcare

₹397.50

-1.80 (-0.45%)

Updated 07:07 am IST

52W Low · ₹268.0052W High · ₹448.00

Near 52W High

Market Cap

₹3709.95L Cr

Volume

49.5K

Prev Close

₹400.25

ISIN

INE742B01025

Orion Score

Fundamentals-based quality & risk · not a recommendation

49/100

Caution

Gufic BioSciences Ltd scores 49/100 (Caution) on the Orion Score — moderate business quality (59), moderate growth (52), weak balance-sheet safety (47) and rich valuation (21). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.7× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(6.60)Beneish M Clean(-2.43)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

66/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Moderate

D/E 0.58x — manageable leverage

QUALITY

Average

ROCE 14.6% — decent returns

MOMENTUM

Neutral

RSI 65.4 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 57.80
ROCE: 14.61%
ROE (1Y): 12.30%
D/E Ratio: 0.58x
OPM: 15.71%
TTM EPS: ₹6.40
Dividend Yield: 3.00%
Qtrly Sales: ₹251.82 Cr
Qtrly Profit: ₹21.90 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹251.82	₹21.9	15.7%	₹2.18
Q3 2026	₹231.41	₹12.42	10.9%	₹1.24
Q2 2026	₹237.05	₹16.82	12.7%	₹1.68
Q1 2026	₹223.72	₹13.07	11.4%	₹1.30
Q4 2025	₹205.02	₹7.72	9.0%	₹0.77

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹944.01	₹64.21	₹153.99	12.8%
FY 2025	₹819.81	₹69.65	₹138.32	13.9%
FY 2024	₹769.66	₹86.14	₹147.45	17.2%
FY 2023	₹679.75	₹79.7	₹135.64	17.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
GUFICBIO ★	₹3,710 Cr	57.80	14.61%	12.30%	0.58x	15.71%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹1,169.36	₹1,092.54	₹861.16	₹521.4
Equity	₹601.08	₹532.56	₹347.81	₹269.12
Total Debt	₹336.19	₹332.92	₹334.19	₹64.39
Cash	₹15.72	₹1.14	₹28.6	₹11.61
Net Debt	₹294.65	₹315.9	₹282.81	₹49.63
Working Capital	₹236.97	₹228.43	₹175.9	₹134.35

Shareholding Pattern

Q1 FY2027

Promoter

77.55%

FII

2.03%

DII

1.66%

Public

18.76%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	77.55% ↑	2.03% ↑	1.66% ↓	18.76% ↓
Q3 FY2026	72.5%	0.44% ↑	3.74% ↑	23.3% ↓
Q2 FY2026	72.5% ↓	0.33% ↑	3.66% ↑	23.51% ↓
Q1 FY2026	72.51%	0.32% ↑	3.38% ↓	23.81% ↑
Q4 FY2025	72.51%	0.31% ↑	3.39% ↑	23.79% ↓
Q3 FY2025	72.51%	0.3% ↑	2.99% ↑	24.2% ↓
Q2 FY2025	72.51%	0.23%	2.51% ↑	24.75% ↓
Q1 FY2025	72.51%	0.23%	2.38%	24.89%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

10 mutual fund schemes

Bank of India Business Cycle Fund Direct GrowthBOI_AXA

1.07%

₹5 Cr

Bank of India Manufacturing & Infrastructure Fund Direct GrowthBOI_AXA

0.84%

₹7 Cr

Bank of India Small Cap Fund Direct GrowthBOI_AXA

0.82%

₹19 Cr

SBI Healthcare Opportunities Fund Direct Plan GrowthSBI

0.37%

₹17 Cr

ICICI Prudential Multicap Fund Direct Plan GrowthICICI_PRUDENTIAL

0.28%

₹49 Cr

ICICI Prudential Smallcap Fund Direct Plan GrowthICICI_PRUDENTIAL

0.17%

₹15 Cr

ICICI Prudential Bharat Consumption Fund Direct GrowthICICI_PRUDENTIAL

0.14%

₹4 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.06%

₹0 Cr

ICICI Prudential ELSS Tax Saver Direct Plan GrowthICICI_PRUDENTIAL

0.02%

₹3 Cr

Motilal Oswal BSE 1000 Index Fund Direct GrowthMOTILAL_OSWAL

0.00%

₹0 Cr

Analyse GUFICBIO with Orion AI

Ask: "Is Gufic BioSciences Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Gufic BioSciences Ltd (GUFICBIO) Stock

Gufic BioSciences Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE742B01025. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.